Hypertension  ||| S:0 E:13 ||| NNP
and  ||| S:13 E:17 ||| CC
renal  ||| S:17 E:23 ||| FW
calcium  ||| S:23 E:31 ||| FW
transport  ||| S:31 E:41 ||| FW
Calcium  ||| S:41 E:49 ||| FW
homeostasis  ||| S:49 E:61 ||| FW
is  ||| S:61 E:64 ||| VBZ
altered  ||| S:64 E:72 ||| VBN
in  ||| S:72 E:75 ||| IN
hypertensive  ||| S:75 E:88 ||| JJ
patients ||| S:88 E:96 ||| NNS
.  ||| S:96 E:98 ||| .
Indeed  ||| S:98 E:105 ||| RB
several  ||| S:105 E:113 ||| JJ
investigators  ||| S:113 E:127 ||| NNS
have  ||| S:127 E:132 ||| VBP
reported  ||| S:132 E:141 ||| VBN
that  ||| S:141 E:146 ||| IN
sodium-sensitive  ||| S:146 E:163 ||| JJ
hypertension  ||| S:163 E:176 ||| NN
is  ||| S:176 E:179 ||| VBZ
associated  ||| S:179 E:190 ||| VBN
with  ||| S:190 E:195 ||| IN
hypercalciuria ||| S:195 E:209 ||| NN
.  ||| S:209 E:211 ||| .
On  ||| S:211 E:214 ||| IN
the  ||| S:214 E:218 ||| DT
other  ||| S:218 E:224 ||| JJ
hand ||| S:224 E:228 ||| NN
,  ||| S:228 E:230 ||| ,
an  ||| S:230 E:233 ||| DT
independent  ||| S:233 E:245 ||| JJ
clinical  ||| S:245 E:254 ||| JJ
association  ||| S:254 E:266 ||| NN
exists  ||| S:266 E:273 ||| VBZ
between  ||| S:273 E:281 ||| IN
the  ||| S:281 E:285 ||| DT
occurrence  ||| S:285 E:296 ||| NN
of  ||| S:296 E:299 ||| IN
urolithiasis  ||| S:299 E:312 ||| NN
and  ||| S:312 E:316 ||| CC
hypertension ||| S:316 E:328 ||| NN
,  ||| S:328 E:330 ||| ,
but  ||| S:330 E:334 ||| CC
the  ||| S:334 E:338 ||| DT
molecular  ||| S:338 E:348 ||| JJ
mechanism ||| S:348 E:357 ||| NN
( ||| S:357 E:358 ||| -LRB-
s ||| S:358 E:359 ||| LS
)  ||| S:359 E:361 ||| -RRB-
involved  ||| S:361 E:370 ||| VBN
in  ||| S:370 E:373 ||| IN
stone  ||| S:373 E:379 ||| NN
formation  ||| S:379 E:389 ||| NN
by  ||| S:389 E:392 ||| IN
high  ||| S:392 E:397 ||| JJ
blood  ||| S:397 E:403 ||| NN
pressure  ||| S:403 E:412 ||| NN
have  ||| S:412 E:417 ||| VBP
not  ||| S:417 E:421 ||| RB
been  ||| S:421 E:426 ||| VBN
so  ||| S:426 E:429 ||| RB
far  ||| S:429 E:433 ||| RB
clarified ||| S:433 E:442 ||| VBN
.  ||| S:442 E:444 ||| .
To  ||| S:444 E:447 ||| TO
understand  ||| S:447 E:458 ||| VB
this  ||| S:458 E:463 ||| DT
association ||| S:463 E:474 ||| NN
,  ||| S:474 E:476 ||| ,
it  ||| S:476 E:479 ||| PRP
is  ||| S:479 E:482 ||| VBZ
obvious  ||| S:482 E:490 ||| JJ
that  ||| S:490 E:495 ||| IN
we  ||| S:495 E:498 ||| PRP
should  ||| S:498 E:505 ||| MD
analyze  ||| S:505 E:513 ||| VB
the  ||| S:513 E:517 ||| DT
effect  ||| S:517 E:524 ||| NN
of  ||| S:524 E:527 ||| IN
hypertension  ||| S:527 E:540 ||| NN
on  ||| S:540 E:543 ||| IN
the  ||| S:543 E:547 ||| DT
transport  ||| S:547 E:557 ||| NN
proteins  ||| S:557 E:566 ||| VBZ
involved  ||| S:566 E:575 ||| VBN
in  ||| S:575 E:578 ||| IN
the  ||| S:578 E:582 ||| DT
renal  ||| S:582 E:588 ||| JJ
calcium  ||| S:588 E:596 ||| NN
handling ||| S:596 E:604 ||| NN
.  ||| S:604 E:606 ||| .
In  ||| S:606 E:609 ||| IN
the  ||| S:609 E:613 ||| DT
kidney ||| S:613 E:619 ||| NN
,  ||| S:619 E:621 ||| ,
the  ||| S:621 E:625 ||| DT
tubular  ||| S:625 E:633 ||| JJ
reabsorption  ||| S:633 E:646 ||| NN
of  ||| S:646 E:649 ||| IN
calcium  ||| S:649 E:657 ||| NN
may  ||| S:657 E:661 ||| MD
proceed  ||| S:661 E:669 ||| VB
through  ||| S:669 E:677 ||| IN
transcellular  ||| S:677 E:691 ||| NN
and  ||| S:691 E:695 ||| CC
paracellular  ||| S:695 E:708 ||| JJ
routes ||| S:708 E:714 ||| NNS
.  ||| S:714 E:716 ||| .
At  ||| S:716 E:719 ||| IN
variance  ||| S:719 E:728 ||| NN
with  ||| S:728 E:733 ||| IN
the  ||| S:733 E:737 ||| DT
proximal  ||| S:737 E:746 ||| JJ
tubule ||| S:746 E:752 ||| NN
,  ||| S:752 E:754 ||| ,
along  ||| S:754 E:760 ||| IN
the  ||| S:760 E:764 ||| DT
distal  ||| S:764 E:771 ||| JJ
segment ||| S:771 E:778 ||| NN
,  ||| S:778 E:780 ||| ,
calcium  ||| S:780 E:788 ||| JJ
transport  ||| S:788 E:798 ||| NN
is  ||| S:798 E:801 ||| VBZ
entirely  ||| S:801 E:810 ||| RB
sodium  ||| S:810 E:817 ||| JJ
independent  ||| S:817 E:829 ||| JJ
and  ||| S:829 E:833 ||| CC
occurs  ||| S:833 E:840 ||| VBZ
via  ||| S:840 E:844 ||| IN
the  ||| S:844 E:848 ||| DT
transcellular  ||| S:848 E:862 ||| JJ
pathway ||| S:862 E:869 ||| NN
.  ||| S:869 E:871 ||| .
In  ||| S:871 E:874 ||| IN
particular ||| S:874 E:884 ||| JJ
,  ||| S:884 E:886 ||| ,
transcellular  ||| S:886 E:900 ||| JJ
calcium  ||| S:900 E:908 ||| NN
reabsorption  ||| S:908 E:921 ||| NN
proceeds  ||| S:921 E:930 ||| NNS
through  ||| S:930 E:938 ||| IN
a  ||| S:938 E:940 ||| DT
well-controlled  ||| S:940 E:956 ||| JJ
sequence  ||| S:956 E:965 ||| NN
of  ||| S:965 E:968 ||| IN
events  ||| S:968 E:975 ||| NNS
consisting  ||| S:975 E:986 ||| VBG
of  ||| S:986 E:989 ||| IN
luminal  ||| S:989 E:997 ||| JJ
calcium  ||| S:997 E:1005 ||| NN
entry  ||| S:1005 E:1011 ||| NN
via  ||| S:1011 E:1015 ||| IN
the  ||| S:1015 E:1019 ||| DT
epithelial  ||| S:1019 E:1030 ||| JJ
calcium  ||| S:1030 E:1038 ||| NN
channel  ||| S:1038 E:1046 ||| NN
( ||| S:1046 E:1047 ||| -LRB-
TRPV5 ||| S:1047 E:1052 ||| NNP
) ||| S:1052 E:1053 ||| -RRB-
,  ||| S:1053 E:1055 ||| ,
cytosolic  ||| S:1055 E:1065 ||| JJ
diffusion  ||| S:1065 E:1075 ||| NN
of  ||| S:1075 E:1078 ||| IN
calcium  ||| S:1078 E:1086 ||| NN
bound  ||| S:1086 E:1092 ||| VBN
to  ||| S:1092 E:1095 ||| TO
calbindin-D28K ||| S:1095 E:1109 ||| CD
,  ||| S:1109 E:1111 ||| ,
and  ||| S:1111 E:1115 ||| CC
basolateral  ||| S:1115 E:1127 ||| JJ
extrusion  ||| S:1127 E:1137 ||| NN
of  ||| S:1137 E:1140 ||| IN
calcium  ||| S:1140 E:1148 ||| NN
through  ||| S:1148 E:1156 ||| IN
the  ||| S:1156 E:1160 ||| DT
Na ||| S:1160 E:1162 ||| NNP
/ ||| S:1162 E:1163 ||| NNP
Ca  ||| S:1163 E:1166 ||| MD
exchanger  ||| S:1166 E:1176 ||| VB
( ||| S:1176 E:1177 ||| -LRB-
NCX1 ||| S:1177 E:1181 ||| NNP
)  ||| S:1181 E:1183 ||| -RRB-
and  ||| S:1183 E:1187 ||| CC
plasma  ||| S:1187 E:1194 ||| FW
membrane  ||| S:1194 E:1203 ||| FW
Ca-ATPase  ||| S:1203 E:1213 ||| FW
( ||| S:1213 E:1214 ||| -LRB-
PMCA ||| S:1214 E:1218 ||| NNP
) ||| S:1218 E:1219 ||| -RRB-
.  ||| S:1219 E:1221 ||| .
It  ||| S:1221 E:1224 ||| PRP
is  ||| S:1224 E:1227 ||| VBZ
highly  ||| S:1227 E:1234 ||| RB
likely  ||| S:1234 E:1241 ||| JJ
that  ||| S:1241 E:1246 ||| IN
these  ||| S:1246 E:1252 ||| DT
proteins  ||| S:1252 E:1261 ||| NNS
may  ||| S:1261 E:1265 ||| MD
be  ||| S:1265 E:1268 ||| VB
altered  ||| S:1268 E:1276 ||| VBN
in  ||| S:1276 E:1279 ||| IN
hypertensive  ||| S:1279 E:1292 ||| JJ
disease  ||| S:1292 E:1300 ||| NN
thus  ||| S:1300 E:1305 ||| RB
justifying  ||| S:1305 E:1316 ||| VBG
and  ||| S:1316 E:1320 ||| CC
explaining  ||| S:1320 E:1331 ||| VBG
the  ||| S:1331 E:1335 ||| DT
reported  ||| S:1335 E:1344 ||| JJ
hypercalciuria ||| S:1344 E:1358 ||| NN
.  ||| S:1358 E:1360 ||| .
Experiments  ||| S:1360 E:1372 ||| NNS
in  ||| S:1372 E:1375 ||| IN
hypertensive  ||| S:1375 E:1388 ||| JJ
strains  ||| S:1388 E:1396 ||| NNS
of  ||| S:1396 E:1399 ||| IN
animals  ||| S:1399 E:1407 ||| NNS
exhibiting  ||| S:1407 E:1418 ||| VBG
hypercalciuria  ||| S:1418 E:1433 ||| NNS
may  ||| S:1433 E:1437 ||| MD
help  ||| S:1437 E:1442 ||| VB
to  ||| S:1442 E:1445 ||| TO
solve  ||| S:1445 E:1451 ||| VB
this  ||| S:1451 E:1456 ||| DT
puzzle ||| S:1456 E:1462 ||| NN
.  ||| S:1462 E:1464 ||| .
